Financials
- Market Capitalization 18.76 M
- Employee 22
- Founded 2018
- CEO N/A
- Website www.jaspertherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00QPZNP97
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-0.46
売上高対価格比率
—
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 4602 | SKYE Skye Bioscience, Inc. - Common Stock | 0.62 USD | -6.06% | -13.89% | -21.52% | -22.50% | 21.79 M USD | ||
| 4621 | KALA KALA BIO, Inc. - Common Stock | 1.05 USD | -3.67% | -28.57% | -60.82% | -81.90% | 19.52 M USD | ||
| 4629 | ATOS Atossa Therapeutics, Inc. - Common Stock | 2.33 USD | -2.92% | -1.27% | -7.17% | +147.87% | 20.06 M USD | ||
| 4631 | LGVN Longeveron Inc. - Class A Common stock | 0.63 USD | 0.00% | -1.56% | -23.17% | +10.27% | 19.62 M USD |